Home

PAOLO CAVAZZA

CIK 1163608 · last filed 2021-07-02

PAOLO CAVAZZA is a corporate insider who has filed 34 SEC Form 4 insider transactions across 3 companies since 2007. Across all open-market trades the lifetime net is −$32.7M, making them a net seller over the disclosed history. 22 SEC filings were submitted jointly with SPA Essetifin.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

34

Lifetime Open-Market Net

-$32.67M

Filer Profile

Reported Address
VIA TESSERETE, 10
LUGANO, V8 V8
Related Filers
SPA Essetifin — 22 joint filings, latest 2023-07-06
S P A APTAFIN — 16 joint filings, latest 2023-07-06
CLAUDIO CAVAZZA — 11 joint filings, latest 2007-11-23
Enrico Cavazza — 11 joint filings, latest 2023-07-06
Francesca Cavazza — 11 joint filings, latest 2023-07-06
Preta Martina Cavazza — 11 joint filings, latest 2023-07-06
Silvia Cavazza — 11 joint filings, latest 2023-07-06
FARMACEUTICA LDA DEFIANTE — 11 joint filings, latest 2007-11-23
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCICLONE PHARMACEUTICALS INC (SCLN) Delisted 10%+ Owner 1,075,284 — — -$32.18M 16 2012-05-02
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted 10%+ Owner 549,100 — — -$488.9K 1 2008-07-07
QUESTCOR PHARMACEUTICALS INC (QSC) Delisted 10%+ Owner 7,248,227 — — $0 1 2007-11-30

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-07-02 — Mixed +1,500,000 $300.0K
2013-09-20 — Buy (P) — $0
2012-12-21 — Other (J) — $0
2012-10-23 — Mixed — $0
2012-05-02 SCICLONE PHARMACEUTICALS INC (SCLN) Delisted Mixed −6,980,938 -$36.65M EDGAR
2011-01-07 — Mixed +2,222,223 $600.0K
2010-06-21 — Mixed +11,535,409 $2.36M
2010-05-25 — Buy (P) +240,000 $0
2009-10-13 — Mixed +1,219,512 $1000.0K
2009-09-28 — Mixed +3,952,569 $1000.0K
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.